Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Epilepsy & Behavior : E&B|October 2, 2010
Retrospective study of seizure-related injuries in older people: a 10-year observationAndrea Lees
Cancers|July 2, 2021
Dying to Survive-The p53 ParadoxAndrea Lees, Tamas Sessler, Simon McDade
Cognition & Emotion|June 13, 2012
Health anxiety, anxiety sensitivity, and attentional biases for pictorial and linguistic health-threat cuesAndrea Lees, Karin Mogg, Brendan P Bradley
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 15, 2017
Loss of nitric oxide-mediated inhibition of purine neurotransmitter release in the colon in the absence of interstitial cells of CajalLeonie Durnin, Andrea Lees, Sheerien Manzoor, et al.
Molecular Pharmaceutics|February 9, 2024
Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic ToxicityAnas Abed, Michelle K Greene, Alhareth A Alsa'd, et al.
Molecular Cancer Therapeutics|August 14, 2021
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal CancerNyree Crawford, Katie J Stott, Tamas Sessler, et al.
Molecular Cancer Therapeutics|January 28, 2022
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 AgonistsVera Grinkevitch, Mark Wappett, Nyree Crawford, et al.
Communications Biology|May 26, 2026
Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative stateShania M Corry, Svetlana Sakhnevych, Noha Ehssan Mohamed, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
The pseudo-caspase FLIP(L) regulates cell fate following p53 activationAndrea Lees, Alexander J McIntyre, Nyree T Crawford, et al.
European Journal of Heart Failure|March 2, 2026
SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart FailureRoss T Campbell, Joanna Osmanska, Kieran F Docherty, et al.
Pageof 1